Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73761/AC_Vidac_280224.001.png
Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Sensationelle Studienergebnisse - 100 mal wirksamer gegen Krebs. 525% Biotech Hot Stock nach 9.290% mit Novo-Nordisk

 

28.02.24 08:03

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Autozone stock price is still in the rally zone: https://www.marketbeat.com/logos/articles/med_20240227110105_chart-azo-22272024ver001.png
Autozone stock price is still in the rally zone

Autozone (NYSE: AZO) shares surged following the FQ2 report, confirming the uptrend is intact. Because the news aligns with the outlook for growth and capital returns, the trend will likely

Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties: https://www.irw-press.at/prcom/images/messages/2024/73753/Westward_022724_ENPRcom.002.png
Westward Gold Outlines 2024 Exploration Goals at Cortez Trend Properties

Vancouver, British Columbia, February 27, 2024 – Westward Gold Inc. (CSE: WG, OTCQB: WGLIF, FSE: IM50) (“Westward” or the “Company”) is pleased to provide preliminary details surrounding

New highs are coming for Lowe’s stock despite mixed results: https://www.marketbeat.com/logos/articles/med_20240227090542_chart-low-2272024ver001.png
New highs are coming for Lowe’s stock despite mixed results

At face value, Lowe’s Companies (NYSE: LOW) had a rough Q4 compared to competitor Home Depot, but the details within the report belie that assessment. Comps were weak, but the company is building

3 lithium stocks to ride a multi-year cycle: https://www.marketbeat.com/logos/articles/med_20240227091730_3-lithium-stocks-to-ride-a-multi-year-cycle.jpg
3 lithium stocks to ride a multi-year cycle

The world used to run on coal and other types of fuel that powered the different titans of industry. This cycle started with transportation through railways to factories and steel mills that were

Goldman upgraded Nvidia stock, one metric says it could go higher: https://www.marketbeat.com/logos/articles/med_20240227091342_goldman-upgraded-nvidia-stock-one-metric-says-it-c.jpg
Goldman upgraded Nvidia stock, one metric says it could go higher

Today's market seems to be all over the hype stories found in the world of technology stocks. This is especially the case with blowout performances by names like Nvidia Corporation (NASDAQ: NVDA)

bluebird bio: How to play LEAPS options for growth and income: https://www.marketbeat.com/logos/articles/med_20240226111048_option-blue-stock.jpg
bluebird bio: How to play LEAPS options for growth and income

Gene-editing is making huge headlines in the medical sector stemming from the first FDA approval for a CRISPR/cas9 treatment for sickle cell disease SCD and TDT from CRISPR Therapeutics AG

Thinking long-term? Don't lose interest in Pinterest: https://www.marketbeat.com/logos/articles/med_20240226120753_thinking-long-term-dont-lose-interest-in-pinterest.jpg
Thinking long-term? Don't lose interest in Pinterest

Pinterest Inc. (NYSE: PINS) stock suffered a 12% sell-off on its Q4 2023 earnings report. The main reason for the selling was a miss on the top line, as revenues failed to beat consensus analyst

Salesforce stock got a boost. Is it growing off the Nvidia boom?: https://www.marketbeat.com/logos/articles/med_20240226114104_salesforce-stock-got-a-boost.jpg
Salesforce stock got a boost. Is it growing off the Nvidia boom?

Most hype surrounds technology stocks, particularly after the king of the sector, Nvidia Corp. (NASDAQ: NVDA), kept breaking past all-time high prices on ever-increasing financial expansion. There

Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73736/aktiencheck27022401.001.png
Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. Neuer 525% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Durchbruch in der Krebsforschung - 100 mal wirksamer gegen Krebs. 525% Biotech Aktientip nach 15.973% mit BioNTech

 

27.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Is The Trade Desk signaling the rebound of digital advertising?: https://www.marketbeat.com/logos/articles/med_20240225154933_chartz-ttd.jpg
Is The Trade Desk signaling the rebound of digital advertising?

The Trade Desk Inc. (NASDAQ: TTD) is a leading independent programmatic advertising technology (AdTech) platform provider. Its demand-side platform (DSP) allows companies to automate their digital

Domino’s stock or Papa John’s? Follow price action to find out: https://www.marketbeat.com/logos/articles/med_20240226091810_dominos-stock-or-papa-johns-follow-price-action-to.jpg
Domino’s stock or Papa John’s? Follow price action to find out

Most of the market is now focused on the hype in the high-flying technology stocks today, where names like NVIDIA (NASDAQ: NVDA) keep delivering insane financial results to help the stock break

Is CRISPR Therapeutics the NVIDIA of gene editing?: https://www.marketbeat.com/logos/articles/med_20240225160343_chart-crsp.jpg
Is CRISPR Therapeutics the NVIDIA of gene editing?

CRISPR Therapeutics AG (NASDAQ: CRSP) made worldwide headlines when it and partner Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) received the first-ever FDA approval for a gene-editing therapy for

Block's multiple ecosystems drive shares higher on 2024 outlook: https://www.marketbeat.com/logos/articles/med_20240225155825_charts-sq.jpg
Block's multiple ecosystems drive shares higher on 2024 outlook

Block Inc. (NYSE: SQ) is a technology company with multiple ecosystems generating a network and cumulative effect. It's most known as a fintech operating its Square segment, which is a digital and

6 reasons to buy Teva Pharmaceuticals stock sooner than later: https://www.marketbeat.com/logos/articles/med_20240225160005_chartm-teva.jpg
6 reasons to buy Teva Pharmaceuticals stock sooner than later

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a global pharmaceutical company in the medical sector specializing in generic and specialty medications. The company has been suffering under

Analysts boosted Snowflake stock, big firms are buying now: https://www.marketbeat.com/logos/articles/med_20240225194338_analysts-boosted-snowflake-stock-big-firms-are-buy.jpg
Analysts boosted Snowflake stock, big firms are buying now

All the market hype is now focusing on the world of technology stocks, especially after the massive run-up in names like Nvidia Corporation (NASDAQ: NVDA) and other companies involved with the

Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73714/aktiencheck26022401.001.png
Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Blockbuster gegen Krebs - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)

 

26.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)

 

 

Link

Bloomin’ Brands could blossom in 2024: https://www.marketbeat.com/logos/articles/med_20240223074736_chart-blmn-2232024ver001.png
Bloomin’ Brands could blossom in 2024

Bloomin’ Brands (NASDAQ: BLMN) served mixed results for Q4 and provided tepid guidance, but repositioning efforts have the restaurant stock set up to blossom in 2024. A massive closure effort

Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73699/AC-230224.001.png
Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. Neuer 415% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: Hautkrebs vollständig geheilt - 100 mal wirksamer gegen Krebs. 415% Biotech Hot Stock nach 15.973% mit BioNTech

 

23.02.24 08:03

AC Research

 

London (www.aktiencheck.de , Anzeige)

 

Keurig-Dr Pepper stock: Time to take another sip?: https://www.marketbeat.com/logos/articles/med_20240222121921_chart-kdp-2222024ver001.png
Keurig-Dr Pepper stock: Time to take another sip?

Keurig Dr Pepper's (NASDAQ: KDP) share price fell following the Q4 results and guidance for 2024, setting up the next buying opportunity. The market is down but aligning with a bottoming pattern

Rivian shares gets discounted; shares can move lower: https://www.marketbeat.com/logos/articles/med_20240222100045_chart-rivn-2222024ver001.png
Rivian shares gets discounted; shares can move lower

Rivian’s (NASDAQ: RIVN) Q4 release further proves that the EV market bubble has burst. Internal metrics and guidance suggest demand has peaked and current capacity is too much. The takeaway is

Top-Rated AMD nears major breakout level: https://www.marketbeat.com/logos/articles/med_20240222062548_amd.jpg
Top-Rated AMD nears major breakout level

While shares of Advanced Micro Devices (NASDAQ: AMD) might not grab the headlines as much as its competitor, Nvidia (NASDAQ: NVDA), shareholders of the global semiconductor company are undoubtedly

AI powerhouse NVIDIA will hit $1000 soon: https://www.marketbeat.com/logos/articles/med_20240222065539_chart-nvda-2222024ver001.png
AI powerhouse NVIDIA will hit $1000 soon

Traders and investors fearing an NVIDIA (NASDAQ: NVDA)-led market correction can put those fears to rest. The company’s Q4 results reveal that the AI market is still strong, stronger than expected

How to use iron condors to collect income from stock options: https://www.marketbeat.com/logos/articles/med_20240221122132_iron-intc.jpg
How to use iron condors to collect income from stock options

Achieving risk-free passive income from the stock market is the dream of investors. Unfortunately, nothing in the stock market are risk-free. However, if you are willing to have a cap on your

Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB): https://www.irw-press.at/prcom/images/messages/2024/73679/aktiencheck22022401.001.png
Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. Neuer 407% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)

Eilt: 100 mal wirksamer gegen Krebs - Hautkrebs vollständig geheilt. 400% Biotech Aktientip nach 9.290% mit Novo-Nordisk

 

22.02.24

AC Research

 

London (www.aktiencheck.de, Anzeige)